Iomeron 400 Iomeron® is a tri-iodinated non-ionic monomeric contrast medium for radiology.

Empower CTA+ The Empower CTA+ Injector System is the robust and intuitive syringe-based injector for CT imaging by Bracco, re-engineered in order to ensure operational efficiencies and patient safety.

Contrast Induced Nephropathy Contrast Induced Nephropathy

Data protection Data Protection

Cookie Policy Cookie Policy

Search

MustKit CT The Tubing Kit is a system which combines an approved multi-use transfer set with dual check valve extenders and a single patient line with two one-way valves.

Pharmacovigilance Pharmacovigilance is the science and activities relating to the detection, assessment, understanding and prevention of adverse events or any other drug-related problem, with the aim to improve the care and safety of patients and to contribute to the protection of public health.

Our president Diana Bracco, born in Milan, is President and CEO of the Bracco Group, a healthcare multinational and world leader in imaging diagnostics with a consolidated turnover of over 1.7 billion euros, around 3,700 employees, and a portfolio of over 2,500 patents. Founded in 1927 by Elio Bracco, the pharmaceutical company annually invests 10% of its imaging diagnostics turnover in research and development.

HSE Policy The Health, Safety, and Environment (HSE) Policy conveys the principles of the Bracco Group on health, safety, and environmental matters.